Eli Lilly and Co (LLY)

77.78
0.82 1.00
NYSE : Health Care
Prev Close 78.60
Open 78.60
Day Low/High 77.63 / 78.60
52 Wk Low/High 67.88 / 92.85
Volume 2.03M
Avg Volume 3.90M
Exchange NYSE
Shares Outstanding 1.10B
Market Cap 86.36B
EPS 2.30
P/E Ratio 33.58
Div & Yield 2.04 (2.60%)

Latest News

Sell These 5 Stocks Now Before They Turn Toxic

Sell These 5 Stocks Now Before They Turn Toxic

It's time to unload these toxic stocks from your portfolio.

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Cyclacel Stock Runs on Momentum Rocket Fueled by 'Dumb & Dumber' Optimism

Shares of biotech micro-cap Cyclacel Pharmaceuticals have doubled in price in the past 10 days. Call it the Lloyd Christmas effect.

Intermediate Level Trade: Eli Lilly

Intermediate Level Trade: Eli Lilly

Consider that the $70 line of support.

Lilly And AstraZeneca Receive FDA Fast Track Designation For AZD3293, An Investigational Treatment For Early Alzheimer's Disease

Lilly And AstraZeneca Receive FDA Fast Track Designation For AZD3293, An Investigational Treatment For Early Alzheimer's Disease

AZD3293 is an oral potent small molecule BACE inhibitor in phase 3 development

Sporting Goods Leveling Field, Which Stocks Say Interest Rates Are Rising: Jim Cramer's Best Blogs

Sporting Goods Leveling Field, Which Stocks Say Interest Rates Are Rising: Jim Cramer's Best Blogs

Jim Cramer ponders how the playing field is being leveled and how three stocks indicate a change in interest rates.

Jim Cramer -- Will Interest Rates Rise? Check These 3 Stocks

Jim Cramer -- Will Interest Rates Rise? Check These 3 Stocks

Johnson & Johnson, American Electric Power and Federal Realty say rates are going higher.

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Cramer: 3 Stocks Say Interest Rates Are Going Higher

Be aware that Johnson & Johnson, American Electric Power and Federal Realty don't roll over idly.

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio

Earlier this month the two major pharmacy benefit managers, CVS Caremark CVS and Express Scripts ESRX released lists of drugs they will no longer cover in 2017.

Why Allergan is Fine Without Large M&A

Why Allergan is Fine Without Large M&A

The Dublin-based drugmaker has some 65-plus mid-to-late stage assets in its pipeline.

Elanco Launches New Video Series Illustrating The Powerful Bond Between Service Dogs, Owners

Elanco Launches New Video Series Illustrating The Powerful Bond Between Service Dogs, Owners

Documentary chronicles the journey of two Canine Assistants recipients as they develop unbreakable bonds with their dogs

Are We Sitting Atop Another 8-Year Peak?

Are We Sitting Atop Another 8-Year Peak?

The market action looks very much like it did before the drops that occurred in 2000 and 2008.

Here Is Jim Cramer's Take on Eli Lilly Shares

Here Is Jim Cramer's Take on Eli Lilly Shares

Jim Cramer says Eli Lilly has been overpromising and underdelivering.

Why I Feel Bearish About the Market

Why I Feel Bearish About the Market

I'm not inclined to make market calls, but the action on my screen is pushing me to a defensive stance.

Watch the $78 Level on Eli Lilly

Watch the $78 Level on Eli Lilly

If buyers don't appear around $78 then a deeper correction is likely.

Eli Lilly And (LLY) Shows Signs Of Being Water-Logged And Getting Wetter

Eli Lilly And (LLY) Shows Signs Of Being Water-Logged And Getting Wetter

Trade-Ideas LLC identified Eli Lilly and (LLY) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Leading U.K. Bank Shares Up Ahead Of BoE Rate Decision

Leading U.K. Bank Shares Up Ahead Of BoE Rate Decision

Investors brace for the first cut - or change - in central bank interest rates in more than seven years.

Biogen Is a Takeover Target but Don't Ignore the Risks

Biogen Is a Takeover Target but Don't Ignore the Risks

The big bounce in Biogen's valuation over the past month would likely bake in a good chunk of the upside premium that could come from any takeover offer.

Insider Trading Alert - LLY, KFS And TILE Traded By Insiders

Insider Trading Alert - LLY, KFS And TILE Traded By Insiders

Stocks with insider trader activity include LLY, KFS and TILE

Trending Tickers: ORCL, N, FB, BA, LLY

Trending Tickers: ORCL, N, FB, BA, LLY

Facebook continued to reap the rewards of its strong quarterly results today.

Eli Lilly's (LLY) New CEO David Ricks Talks Strategy with CNBC

Eli Lilly's (LLY) New CEO David Ricks Talks Strategy with CNBC

Eli Lilly (LLY) current CEO John Lechleiter steps down and new CEO David Ricks shares his plans for the company.

Eli Lilly Names its Next CEO

Eli Lilly Names its Next CEO

The pharmaceutical giant tapped a 20-year company veteran to succeed John Lechleiter, who will retire as president and CEO at yearend.

3 Drugs Stocks Pushing Industry Growth

3 Drugs Stocks Pushing Industry Growth

TheStreet highlights 3 stocks pushing the drugs industry higher today.

Eli Lilly (LLY) Announces Resignation of CEO John Lichleiter, CNBC Reports

Eli Lilly (LLY) Announces Resignation of CEO John Lichleiter, CNBC Reports

Eli Lilly (LLY) announced the resignation of CEO John Lichleiter at the end of 2016.

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

Experimental Tau Protein Drug Tangled Up in Late-Stage Alzheimer's Study Failure

A TauRx Therapeutics drug designed to dissolve tangles of a protein called tau in the brain failed to slow cognitive and functional declines of Alzheimer's patients compared with a control.

Midday Report: New Home Sales Highest Since 2008; U.S. Stocks Mixed

Midday Report: New Home Sales Highest Since 2008; U.S. Stocks Mixed

U.S. stocks retreat into the red as a number of positive and negative earnings reports keep trading choppy.